JP2018537517A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018537517A5 JP2018537517A5 JP2018535221A JP2018535221A JP2018537517A5 JP 2018537517 A5 JP2018537517 A5 JP 2018537517A5 JP 2018535221 A JP2018535221 A JP 2018535221A JP 2018535221 A JP2018535221 A JP 2018535221A JP 2018537517 A5 JP2018537517 A5 JP 2018537517A5
- Authority
- JP
- Japan
- Prior art keywords
- group
- pharmaceutically acceptable
- combination
- acceptable salt
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021176691A JP7261850B2 (ja) | 2015-09-24 | 2021-10-28 | 肝毒性および脂肪性肝疾患の処置に有効な化合物およびその使用 |
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562222959P | 2015-09-24 | 2015-09-24 | |
| US62/222,959 | 2015-09-24 | ||
| US201562257697P | 2015-11-19 | 2015-11-19 | |
| US62/257,697 | 2015-11-19 | ||
| PCT/CN2016/078039 WO2017084234A1 (zh) | 2015-11-19 | 2016-03-31 | 预防或治疗脂肪肝的药物组合物 |
| CNPCT/CN2016/078039 | 2016-03-31 | ||
| PCT/CN2016/100187 WO2017050298A1 (en) | 2015-09-24 | 2016-09-26 | Compounds effective in treating hepatotoxicity and fatty liver diseases and uses thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021176691A Division JP7261850B2 (ja) | 2015-09-24 | 2021-10-28 | 肝毒性および脂肪性肝疾患の処置に有効な化合物およびその使用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2018537517A JP2018537517A (ja) | 2018-12-20 |
| JP2018537517A5 true JP2018537517A5 (enExample) | 2019-11-07 |
Family
ID=60047309
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018535221A Pending JP2018537517A (ja) | 2015-09-24 | 2016-09-26 | 肝毒性および脂肪性肝疾患の処置に有効な化合物およびその使用 |
| JP2021176691A Active JP7261850B2 (ja) | 2015-09-24 | 2021-10-28 | 肝毒性および脂肪性肝疾患の処置に有効な化合物およびその使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021176691A Active JP7261850B2 (ja) | 2015-09-24 | 2021-10-28 | 肝毒性および脂肪性肝疾患の処置に有効な化合物およびその使用 |
Country Status (20)
| Country | Link |
|---|---|
| US (4) | US10456371B2 (enExample) |
| EP (3) | EP4609911A3 (enExample) |
| JP (2) | JP2018537517A (enExample) |
| KR (2) | KR20240042148A (enExample) |
| CN (3) | CN107614475A (enExample) |
| AU (3) | AU2016327930B2 (enExample) |
| BR (1) | BR112018005905B1 (enExample) |
| CA (2) | CA2999368A1 (enExample) |
| EA (1) | EA201890810A1 (enExample) |
| ES (1) | ES3044383T3 (enExample) |
| HK (1) | HK1244266A1 (enExample) |
| HR (1) | HRP20250899T1 (enExample) |
| HU (1) | HUE072982T2 (enExample) |
| MX (2) | MX395231B (enExample) |
| MY (1) | MY190647A (enExample) |
| PH (1) | PH12018500659A1 (enExample) |
| SG (1) | SG10202002573RA (enExample) |
| TW (1) | TWI781912B (enExample) |
| WO (1) | WO2017050298A1 (enExample) |
| ZA (1) | ZA201802373B (enExample) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2016520100A (ja) * | 2013-11-13 | 2016-07-11 | ▲財▼▲団▼法人国防教育研究基金会Ｎａｔｉｏｎａｌ Ｄｅｆｅｎｓｅ Ｅｄｕｃａｔｉｏｎ Ａｎｄ Ｒｅｓｅａｒｃｈ Ｆｏｕｎｄａｔｉｏｎ | 肝臓に対する副作用がない、新しいアセトアミノフェン複合組成 |
| ES3044383T3 (en) | 2015-09-24 | 2025-11-26 | Sinew Pharma Inc | Mannitol for use in treating hepatotoxicity and fatty liver diseases |
| TWI711464B (zh) * | 2015-11-19 | 2020-12-01 | 欣耀生醫股份有限公司 | 預防或治療脂肪肝、保護肝功能、或改善脂肪肝引起的肝病變或其他相關病症之組合物及方法 |
| SG11202007314QA (en) * | 2018-02-14 | 2020-08-28 | Sinew Pharma Inc | Methods and compositions for preventing, reducing or eradicating toxicity caused by acetaminophen (apap) |
| CN110538187A (zh) * | 2018-05-28 | 2019-12-06 | 北京大学 | Cpt1激活剂 |
| KR102136326B1 (ko) * | 2018-09-06 | 2020-07-22 | 서울대학교산학협력단 | 가시박으로부터 분리한 플라보노이드 유도체를 유효성분으로 포함하는 간 질환 예방 또는 치료용 조성물 |
| TWI691719B (zh) * | 2018-10-19 | 2020-04-21 | 香港商阿瓦隆 海帕波有限公司 | 半乳糖快速定量檢測系統及其應用 |
| CN109920550A (zh) * | 2018-12-25 | 2019-06-21 | 天津大学 | 一种基于dMRI研究青少年肌阵挛性癫痫的方法 |
| AU2020211695A1 (en) * | 2019-01-21 | 2021-09-02 | National University Of Singapore | Treatment of hepatotoxicity |
| CN110269855A (zh) * | 2019-07-19 | 2019-09-24 | 辽宁大学 | 黄酮类小分子化合物在制备抑制胰脂肪酶活性药物中的应用 |
| US12383191B1 (en) * | 2020-05-04 | 2025-08-12 | PathAI, Inc. | Systems and methods for assessing liver pathology |
| CN113999272A (zh) * | 2021-10-29 | 2022-02-01 | 广西医科大学 | 香蜂草苷的制备方法及其应用 |
| CN113875982A (zh) * | 2021-11-19 | 2022-01-04 | 武汉森澜生物科技有限公司 | 一种含二氢杨梅素的抗衰组合物及其应用 |
| CN117482082A (zh) * | 2023-11-27 | 2024-02-02 | 西北大学 | 金松双黄酮在制备抗慢性肾损伤药物中的应用 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4661519A (en) * | 1983-04-12 | 1987-04-28 | Pola Chemical Industries Inc. | Method for dermatological application |
| CH664150A5 (de) * | 1985-01-15 | 1988-02-15 | Peter Paul Prof Dr Speiser | Fumarsaeureprodrug, verfahren zu seiner herstellung und dieses enthaltende darreichungsformen. |
| JP3916685B2 (ja) * | 1996-02-29 | 2007-05-16 | 第一製薬株式会社 | ガラクトース誘導体 |
| JP4677550B2 (ja) * | 2002-08-14 | 2011-04-27 | 独立行政法人産業技術総合研究所 | 環状エステル化合物 |
| TWI287990B (en) * | 2004-01-08 | 2007-10-11 | Nat Defense Medical Ct | Inhibitors and enhancers of uridine diphosphate-glucuronosyl transferase 2B (UGT2B) |
| US20070009441A1 (en) * | 2004-07-08 | 2007-01-11 | Molecular Therapeutics, Inc. | Biodegradable nanoparticles |
| CN1939929A (zh) * | 2005-09-29 | 2007-04-04 | 云南白药集团股份有限公司 | 一种偏诺皂苷类化合物酸式盐及制备方法 |
| CN108465110A (zh) * | 2011-04-20 | 2018-08-31 | 教育研究基金会 | 无/低副作用的抗结核病药物复方 |
| US20150291721A1 (en) * | 2012-11-12 | 2015-10-15 | Segetis, Inc. | Crosslinkable polyketal esters, methods of manufacture and uses thereof |
| US9211298B2 (en) * | 2012-11-16 | 2015-12-15 | Song Gao | Compositions containing enriched natural crocin and/or crocetin, and their therapeutic or nutraceutical uses |
| US9149491B2 (en) * | 2013-04-29 | 2015-10-06 | Harsha Chigurupati | Reduced toxicity in alcoholic beverages |
| TWI552748B (zh) | 2013-10-25 | 2016-10-11 | The use of a compound for the removal of hepatotoxicity against Acetaminophen (APAP) | |
| CN104623670A (zh) * | 2013-11-06 | 2015-05-20 | 高松 | 一种含西红花素的组合物及其应用 |
| JP2016520100A (ja) * | 2013-11-13 | 2016-07-11 | ▲財▼▲団▼法人国防教育研究基金会Ｎａｔｉｏｎａｌ Ｄｅｆｅｎｓｅ Ｅｄｕｃａｔｉｏｎ Ａｎｄ Ｒｅｓｅａｒｃｈ Ｆｏｕｎｄａｔｉｏｎ | 肝臓に対する副作用がない、新しいアセトアミノフェン複合組成 |
| CN104292289B (zh) * | 2014-07-10 | 2017-12-29 | 程怡 | 半乳糖配体及其在肝靶向脂质体中的应用 |
| ES3044383T3 (en) * | 2015-09-24 | 2025-11-26 | Sinew Pharma Inc | Mannitol for use in treating hepatotoxicity and fatty liver diseases |
| TWI711464B (zh) * | 2015-11-19 | 2020-12-01 | 欣耀生醫股份有限公司 | 預防或治療脂肪肝、保護肝功能、或改善脂肪肝引起的肝病變或其他相關病症之組合物及方法 |
-
2016
- 2016-09-26 ES ES21173210T patent/ES3044383T3/es active Active
- 2016-09-26 SG SG10202002573RA patent/SG10202002573RA/en unknown
- 2016-09-26 HK HK18103735.4A patent/HK1244266A1/zh unknown
- 2016-09-26 HU HUE21173210A patent/HUE072982T2/hu unknown
- 2016-09-26 KR KR1020247008968A patent/KR20240042148A/ko active Pending
- 2016-09-26 KR KR1020187011548A patent/KR102891137B1/ko active Active
- 2016-09-26 CN CN201680020530.XA patent/CN107614475A/zh active Pending
- 2016-09-26 CA CA2999368A patent/CA2999368A1/en active Pending
- 2016-09-26 TW TW105131118A patent/TWI781912B/zh active
- 2016-09-26 JP JP2018535221A patent/JP2018537517A/ja active Pending
- 2016-09-26 CA CA3232521A patent/CA3232521A1/en active Pending
- 2016-09-26 CN CN202510528240.7A patent/CN120398980A/zh active Pending
- 2016-09-26 EP EP25188784.0A patent/EP4609911A3/en active Pending
- 2016-09-26 AU AU2016327930A patent/AU2016327930B2/en active Active
- 2016-09-26 WO PCT/CN2016/100187 patent/WO2017050298A1/en not_active Ceased
- 2016-09-26 BR BR112018005905-6A patent/BR112018005905B1/pt active IP Right Grant
- 2016-09-26 MY MYPI2018701141A patent/MY190647A/en unknown
- 2016-09-26 US US15/564,526 patent/US10456371B2/en active Active
- 2016-09-26 EP EP21173210.2A patent/EP3991724B1/en active Active
- 2016-09-26 EP EP16848179.4A patent/EP3353144A4/en active Pending
- 2016-09-26 CN CN202510506442.1A patent/CN120349362A/zh active Pending
- 2016-09-26 HR HRP20250899TT patent/HRP20250899T1/hr unknown
- 2016-09-26 MX MX2018003700A patent/MX395231B/es unknown
- 2016-09-26 EA EA201890810A patent/EA201890810A1/ru unknown
-
2018
- 2018-03-23 MX MX2022007816A patent/MX2022007816A/es unknown
- 2018-03-23 PH PH12018500659A patent/PH12018500659A1/en unknown
- 2018-04-11 ZA ZA2018/02373A patent/ZA201802373B/en unknown
-
2019
- 2019-09-17 US US16/573,506 patent/US11285123B2/en active Active
-
2021
- 2021-07-14 AU AU2021205040A patent/AU2021205040B2/en active Active
- 2021-10-28 JP JP2021176691A patent/JP7261850B2/ja active Active
-
2022
- 2022-03-03 US US17/686,013 patent/US12083088B2/en active Active
-
2024
- 2024-02-14 AU AU2024200963A patent/AU2024200963B2/en active Active
- 2024-06-13 US US18/742,433 patent/US20240335404A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Cencig et al. | Evaluation of benznidazole treatment combined with nifurtimox, posaconazole or AmBisome® in mice infected with Trypanosoma cruzi strains | |
| JP2021119180A (ja) | ウロリチンまたはその前駆体の投与によるオートファジーの増強または寿命の延長 | |
| KR101435242B1 (ko) | 간염치료용 실리비닌 성분 | |
| JP2018514589A5 (enExample) | ||
| US20160051536A1 (en) | Compositions to alleviate presystemic metabolism of opioids | |
| JP7175897B2 (ja) | 非アルコール性脂肪性肝炎（ｎａｓｈ）および肝線維症のための併用療法 | |
| EP3518936B1 (en) | Pharmaceutical composition for treatment of non-alcoholic fatty liver disease | |
| JP2018534323A5 (enExample) | ||
| KR20200131816A (ko) | 캡시드 조립 조절제 투약 요법 | |
| WO2023037254A1 (en) | Methods and compounds for treating coronaviridae virus infections | |
| US20030166584A1 (en) | Cytochrome P450 3A inhibitors and enhancers | |
| TW201718015A (zh) | 預防或治療脂肪肝、保護肝功能、或改善脂肪肝引起的肝病變或其他相關病症之組合物及方法 | |
| JP2010506908A (ja) | グルコサミンまたはグルコサミン誘導体を含むアトピー性皮膚炎治療用組成物およびこれらを使用しアトピー性皮膚炎を治療する方法 | |
| JP2006511538A5 (enExample) | ||
| CN114096257A (zh) | 包含如sglt 1/2抑制剂的sglt抑制剂的治疗 | |
| EP2870964A2 (en) | Composition for preventing or treating colitis comprising s-allyl-l-cysteine as active ingredient, and medical preparation comprising same | |
| KR20190087572A (ko) | 양극성 장애의 예방, 경감 또는 치료를 위한 카바메이트 화합물의 용도 | |
| US20210322324A1 (en) | Method for treating primary sclerosing cholangitis | |
| KR102076137B1 (ko) | 수축력 저하 수반성 배뇨근 과활동 개선제 | |
| WO2022161468A1 (en) | Compositions of berberine ursodeoxycholate and methods thereof for treating primary sclerosing cholangitis | |
| WO2001085155A1 (en) | Method and compositions for inhibiting arteriosclerosis | |
| US20210361623A1 (en) | Thioureylene liquid compositions | |
| WO2022048618A1 (en) | Methods to treat inflammatory bowel disease | |
| US20140066519A1 (en) | Use of xanthohumol and/or isoxanthohumol as an agent for preventing and/or combating liver diseases | |
| WO2005030198A1 (ja) | 脂肪肝又は肝疾患を治療するための医薬組成物 |